CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Dyspepsia - pregnancy-associated - Management
What drug treatment should I prescribe?
- Antacids or alginates are recommended as first-line treatments if symptoms are relatively mild and are not controlled adequately by lifestyle changes.
- Antacid products containing combinations of aluminium and magnesium are recommended on an 'as required' basis.
- Calcium-containing products are recommended for short-term or occasional use.
- Alginate products are particularly useful if symptoms of gastro-oesophageal reflux are dominant.
- If symptoms are severe, or persist despite treatment with an antacid or alginate, consider prescribing an acid-suppressing drug:
- Ranitidine is an established drug but is not licensed for use in pregnancy.
- Omeprazole is a more effective alternative. It is licensed for use in pregnancy, but there is less experience of its use in this context.
In depth
© NHS Institute for Innovation and Improvement